Northcape Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Northcape Wealth Management's ABBV Position: Q2 2026 in Review
Northcape Wealth Management increased its AbbVie (ABBV) stake by 7% in Q2 2026, buying an estimated $170K and bringing the position to 12,110 shares worth $3.05M. The position accounts for 0.8% of the portfolio, ranked #44.
Northcape Wealth Management first reported a position in ABBV in Q4 2021 and has held it in 18 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Northcape Wealth Management held 12,110 shares of AbbVie worth $3.05M as of Q2 2026.
- Northcape Wealth Management bought 788 AbbVie shares in Q2 2026, an estimated $170K.
- AbbVie made up 0.8% of Northcape Wealth Management's portfolio in Q2 2026, its #44 holding.
- Northcape Wealth Management first reported a position in AbbVie in Q4 2021 and has held it in 18 quarters since.
- 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Northcape Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.